1921
Volume 88, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Lassa fever is an acute and sometimes severe viral hemorrhagic illness endemic in West Africa. One important question regarding Lassa fever is the duration of immunoglobulin G (IgG) antibody after infection. We were able to locate three persons who worked in Nigeria dating back to the 1940s, two of whom were integrally involved in the early outbreaks and investigations of Lassa fever in the late 1960s, including the person from whom Lassa virus was first isolated. Two persons had high titers of Lassa virus-specific IgG antibody over 40 years after infection, indicating the potential for long-term duration of these antibodies. One person was likely infected in 1952, 17 years before the first recognized outbreak. We briefly recount the fascinating stories of these three pioneers and their important contribution to our understanding of Lassa fever.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.12-0466
2013-02-06
2017-11-24
Loading full text...

Full text loading...

/deliver/fulltext/14761645/88/2/241.html?itemId=/content/journals/10.4269/ajtmh.12-0466&mimeType=html&fmt=ahah

References

  1. Enria DA, Mills JN, Bausch D, Shieh W, Peters CJ, Guerrant RL, Walker DH, Weller PF, , 2011. Arenavirus infections. , eds. Tropical Infectious Diseases: Principles, Pathogens, and Practice, 3rd ed. Philadelphia, PA: Churchill Livingstone, 449461.[Crossref]
  2. Frame JD, Baldwin JM, Jr Gocke DJ, Troup JM, , 1970. Lassa fever, a new virus disease of man from West Africa. I. Clinical description and pathological findings. Am J Trop Med Hyg 19: 670676.
  3. Bausch DG, Rollin PE, Demby AH, Coulibaly M, Kanu J, Conteh AS, Wagoner KD, McMullan LK, Bowen MD, Peters CJ, Ksiazek TG, , 2000. Diagnosis and clinical virology of Lassa fever as evaluated by enzyme-linked immunosorbent assay, indirect fluorescent-antibody test, and virus isolation. J Clin Microbiol 38: 26702677.
  4. Wulff H, Lange JV, , 1975. Indirect immunofluorescence for the diagnosis of Lassa fever infection. Bull World Health Organ 52: 429436.
  5. Van der Waals FW, Pomeroy KL, Goudsmit J, Asher DM, Gajdusek DC, , 1986. Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. Trop Geogr Med 38: 209214.
  6. Fabiyi A, , 1976. Lassa fever (arenaviruses) as a public health problem. Bull Pan Am Health Organ 10: 335337.
  7. McCormick JB, Webb PA, Krebs JW, Johnson KM, Smith ES, , 1987. A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis 155: 437444.[Crossref]
  8. Pinneo L, Pinneo R, , 1971. Mystery virus from Lassa. Am J Nurs 71: 13521355.
  9. Carey DE, Kemp GE, White HA, Pinneo L, Addy RF, Fom AL, Stroh G, Casals J, Henderson BE, , 1972. Lassa fever. Epidemiological aspects of the 1970 epidemic, Jos, Nigeria. Trans R Soc Trop Med Hyg 66: 402408.[Crossref]
  10. Frame JD, , 1975. Surveillance of Lassa fever in missionaries stationed in West Africa. Bull World Health Organ 52: 593598.
  11. Troup JM, White HA, Fom AL, Carey DE, , 1970. An outbreak of Lassa fever on the Jos plateau, Nigeria, in January–February 1970. A preliminary report. Am J Trop Med Hyg 19: 695696.
  12. White HA, , 1972. Lassa fever. A study of 23 hospital cases. Trans R Soc Trop Med Hyg 66: 390401.[Crossref]
  13. Edington GM, White HA, , 1972. The pathology of Lassa fever. Trans R Soc Trop Med Hyg 66: 381389.[Crossref]
  14. Hastie KM, Liu T, Li S, King LB, Ngo N, Zandonatti MA, Woods VL, Jr de la Torre JC, Saphire EO, , 2011. Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci USA 108: 1936519370.[Crossref]
  15. Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS, Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ, Hensley LE, Seisay A, Fair JN, Garry RF, , 2011. Capacity building permitting comprehensive monitoring of a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive outcome: case report. Virol J 8: 314.[Crossref]
  16. Schieffelin JS, Costin JM, Nicholson CO, Orgeron NM, Fontaine KA, Isern S, Michael SF, Robinson JE, , 2010. Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient. Virol J 7: 28.[Crossref]
  17. Fisher-Hoch SP, McCormick JB, , 2001. Towards a human Lassa fever vaccine. Rev Med Virol 11: 331341.[Crossref]
  18. Fulhorst CF, Milazzo ML, Armstrong LR, Childs JE, Rollin PE, Khabbaz R, Peters CJ, Ksiazek TG, , 2007. Hantavirus and arenavirus antibodies in persons with occupational rodent exposure. Emerg Infect Dis 13: 532538.[Crossref]
  19. Bowen MD, Rollin PE, Ksiazek TG, Hustad HL, Bausch DG, Demby AH, Bajani MD, Peters CJ, Nichols ST, , 2000. Genetic diversity among Lassa virus strains. J Virol 74: 69927004.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.12-0466
Loading
/content/journals/10.4269/ajtmh.12-0466
Loading

Data & Media loading...

  • Received : 01 Aug 2012
  • Accepted : 11 Nov 2012

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error